The Vial Fill-Finish Process: Where the Seal Enters the Line and What It Has to Do

Capping station on a vial fill-finish line crimping aluminium-plastic seals onto stoppered vials

Vial fill-finish is the final manufacturing stage for an injectable drug: the sterile product is filled into clean vials, stoppered, freeze-dried where required, capped with an aluminium or aluminium-plastic seal, inspected and released. The seal enters at one point only, the capping station after stoppering, and it is the step that turns a stoppered vial into a closed package. Everything the seal has to do on that line (feed without jamming, crimp the same way on every vial, hold the stopper under compression for the shelf life, and arrive clean enough for the zone it enters) is set by its dimensions, its materials and the form in which it is supplied.

This guide walks the fill-finish chain end to end and, at each stage, sets out what the closure needs and which component does the work. It is written for the people who specify, qualify and buy the seal and stopper for a filling line, rather than for anyone looking for a filling service.

Key takeaways

Fill-finish runs as two streams that meet at the filling machine: the sterile-filtered product and the prepared components (vial, stopper and seal).
The seal enters at the capping station, after stoppering, and after freeze-drying for a lyophilised product. Until the crimp is made, the stopper is held by friction alone and can lift.
Under EU GMP Annex 1 (sections 8.26 to 8.29), where capping runs as a clean process outside the aseptic processing area, stoppered vials are protected by a Grade A air supply until the cap is crimped, and vials with missing or displaced stoppers are rejected before capping by qualified automated stopper-height detection.
Only Ready-to-Use seals go straight into an aseptic core: gamma or ETO sterilized and double-bagged. Ready-to-Sterilize seals need the customer’s own validated cycle; Regular seals suit capping as a clean process outside the core.
Capping speed is limited by how the seal feeds and orients, so the spread of seal dimensions inside a lot matters as much as the nominal size.
Integrity comes from the crimp: the aluminium skirt rolled under the neck flange holds the stopper compressed against the glass, which is why seal height, metal thickness and stopper height are specified together.
Every filled unit is 100% visually inspected after capping, and package integrity is shown separately by container closure integrity testing.

What fill-finish means

Fill-finish covers everything from the point a formulated, filterable bulk exists to the point sealed vials are released for packing. Upstream of it sits drug substance manufacture and formulation; downstream sits distribution. Fill-finish is where the product first meets its final container, which is why regulators treat it as the highest-risk stage of a sterile product’s manufacture, and why the closure components are qualified as part of the product rather than bought as commodities.

Two production models exist. In terminal sterilisation, the product is filled and sealed and the closed unit is then sterilised, usually by moist heat, so the seal and stopper have to survive that cycle. In aseptic processing, the product and every component are sterilised separately and brought together in a controlled environment, because the formulation cannot survive a terminal cycle. Most biologics, most vaccines and most lyophilised products use aseptic processing, and it is the harder case for a closure supplier, since sterility depends on the process rather than on a final kill step. The FDA’s guidance on sterile drug products produced by aseptic processing (September 2004) and EU GMP Annex 1 set the expectations.

The fill-finish line, stage by stage, and what the closure needs at each

The closure components touch almost every stage of the line, and at each one a different property of the vial, stopper or seal decides whether the stage runs cleanly. The table maps the whole chain.

Stage	What happens	What the closure needs here	Component
Component preparation	Vials washed and depyrogenated; stoppers washed, siliconised and sterilised; seals prepared for the zone they enter	Low bioburden and particulate load on arrival; a supply form that matches the site’s transfer route	Stopper, seal
Sterile filtration	Bulk passed through a sterilising-grade filter to the filling manifold	Nothing yet, but the stopper compound has already been chosen for compatibility with this formulation	Stopper
Filling	Product dosed into each open vial under unidirectional airflow	Vial neck finish that matches the stopper and seal drawings	Vial
Stoppering	Stopper pressed into the vial mouth, or seated part-way for freeze-drying	Stopper dimensions and machinability; slotted design for lyophilisation	Stopper
Freeze-drying (where used)	Water removed; shelves press stoppers home at the end of the cycle	Stopper that seats fully and stays seated until capping	Stopper
Capping	Seal fed, placed and crimped under the neck flange	Consistent diameter, skirt height and metal thickness; clean feeding; the right delivery form	Seal
Inspection and integrity	100% visual inspection, then container closure integrity testing	A crimp that holds compression; no loose particles from the seal	Seal and stopper together

The rest of this guide follows that order.

The component stream: preparing the vial, stopper and seal

Before anything is filled, the primary packaging has to arrive clean and be rendered free of viable organisms and, for the glass, of endotoxin. The three components take three different routes, and the route for each one is decided partly by how it is supplied.

Glass vials are washed with purified and water-for-injection rinses, then passed through a dry heat tunnel. The tunnel both sterilises and depyrogenates: USP <1228.1> covers dry heat depyrogenation, and a cycle is validated by showing at least a 3 log (1000 fold) reduction of a bacterial endotoxin challenge, typically at 250 °C or higher for a defined dwell. Vials exit the tunnel into the filling zone, so the tunnel is also the physical boundary into the aseptic core.
Rubber stoppers are washed, siliconised where the design calls for it, and sterilised by moist heat, or bought ready-to-sterilise or ready-to-use in sterile bags. They must also be dried, because residual moisture affects both filling and lyophilisation. Stopper compounds for injectable vials are typically chlorobutyl or bromobutyl rubber, specified against USP <381> and Ph. Eur. 3.2.9, and chosen for compatibility with the formulation. The vial closure rubber types guide compares the families.
Aluminium and aluminium-plastic seals are supplied clean, and their route depends on where capping happens: sterilised caps for an aseptic capping process, or clean seals for capping outside the aseptic processing area (the handover and supply-form sections below set out which form fits which). Either way the incoming cleanliness of the seal matters, since it is the last component to touch the closed vial.

Component preparation is not a side activity. It is a parallel production line with its own validated cycles, its own hold times and its own records, and a delay in it stops the filling line. Buying a component in a form that removes one of those cycles from the site (a Ready-to-Use seal, a ready-to-use stopper) removes a validated process and its records along with it.

The product stream: formulation to sterile filtration

On the product side, the bulk is compounded, controlled for bioburden, and sterile-filtered on its way to the filling needles. Compounding dissolves or dilutes the drug substance with excipients to the target concentration, with in-process checks on pH, appearance and assay. Bioburden is measured on the pre-filtration bulk, because a sterilising filter is validated against a defined challenge rather than an unlimited one.

Sterile filtration then passes the bulk through a sterilising-grade filter, conventionally rated at 0.22 µm or finer, into a sterile holding vessel or straight to the filling manifold. Filter integrity is tested before and after use, and a post-use failure invalidates the batch behind it. For products that cannot be filtered, the sterility assurance strategy changes entirely, but for the large majority of vialled injectables this is the step that makes the product sterile.

The closure has no job at this stage, but it has already been decided here. The formulation’s pH, its solvents and its sensitivity to oxygen and moisture are what the stopper compound was chosen against, and the vial closure as a system, stopper, seal and neck finish together, is qualified for this specific product before the first commercial batch is filled.

Filling, stoppering and freeze-drying

Filling doses the product into each vial; stoppering seats the elastomeric closure that will form the sterile barrier. Filling is by peristaltic, rotary piston, time-pressure or mass-flow systems depending on volume and shear sensitivity, with in-process fill weight checks at set intervals and, on many lines, 100% check-weighing. The open vial is exposed only inside the highest-grade zone, under unidirectional airflow, in an isolator or a restricted access barrier system.

Stoppering follows immediately. The stopper is placed and pressed into the vial mouth so its sealing surfaces contact the glass. At this point the vial is closed but not sealed: the stopper is held only by friction and can be displaced, which is why the stopper’s dimensions and its surface treatment decide how reliably it stays put on the way to the capper.

For a lyophilised product the sequence branches. Slotted freeze-drying stoppers are seated in a raised position so water vapour can escape, the loaded vials go into the freeze-dryer, and at the end of the cycle the dryer shelves press every stopper fully home, often under vacuum or an inert gas, before the chamber is opened. Only then do the vials go to capping. The seal crimped over a stopper that has just come out of a freeze-dryer is covered on the lyophilization vial seals page, which Autofits makes in 13 and 20 mm.

The handover from stoppering to capping

Between the stoppering station and the capping station, a vial is closed but not sealed, and that interval is where most closure-related risk on a fill-finish line sits. The stopper can rise, the vial can be jostled on a transfer, and on many lines the vial leaves the aseptic core before it reaches the capper. Three things govern the handover.

Where the capper sits. Annex 1 allows capping of aseptically filled product either as an aseptic process using sterilised caps or as a clean process outside the aseptic processing area. Crimping equipment can generate large quantities of non-viable particles, and Annex 1 asks for measures such as a physically separate station with adequate air extraction, which is one reason capping outside the core is common. The choice fixes which delivery form of seal the line can use.
How the stoppered vial is protected on the way. Where capping is outside the core, vials are kept under Grade A conditions until they leave the aseptic processing area, then under a Grade A air supply until the cap has been crimped, with a background of at least Grade D. Annex 1 defines a Grade A air supply as air through a filter qualified to produce Grade A particle quality, without the continuous particle monitoring or Grade A viable limits of a Grade A zone. Manual capping is done under Grade A conditions, in an isolator or in Grade A with a Grade B background.
What happens to a vial with a raised or missing stopper. Annex 1 expects these to be rejected before capping, using qualified automated stopper-height detection. A raised stopper that gets crimped over produces a unit that can look acceptable at inspection and is not integral, so the check sits upstream of the seal.

Lyophilised product adds a hold: loaded vials wait in the freeze-dryer for the length of the cycle, and after unloading they wait again for the capper. The hold time between stoppering and capping is validated for the product, and a capper that stops because a seal has jammed eats into that window for every vial queued behind it. The machine side of this, from inline to rotary cappers and how their reject logic works, is set out in automated vial capping systems.

Capping: where the seal enters the line

The seal enters the line at exactly one point: the capping station, immediately after stoppering, and after lyophilisation where the product is freeze-dried. Capping is the step that turns a stoppered vial into a sealed package, by crimping an aluminium or aluminium-plastic seal over the stopper and under the vial neck flange. Until this happens the stopper can lift, so capping is where the container closure system actually becomes a system.

The station itself has a defined sequence. Seals are tipped into a hopper or bowl feeder, oriented and singulated, fed down a chute onto each stoppered vial as it indexes past, then formed by crimping rollers or a servo-controlled head that rolls the aluminium skirt under the flange. Like the stopper before it, the seal is handled in bulk, mechanically oriented and applied at line speed, which is why its feeding behaviour matters as much as its dimensions.

Beyond the handover rules above, Annex 1 asks that where people have to intervene at the capping station, technological and organisational measures prevent direct contact with the vials, and notes that restricted access barrier systems and isolators may help. The mechanics of the crimp itself are covered in vial crimping explained, the sterility controls around it in sterile vial sealing, and the equipment that carries it out, from bench-top crimpers to inline rotary cappers, in vial sealing machine types.

Most injectable vials take a FlipTop Optima flip-off seal, an aluminium skirt with a polypropylene disc that the user flips off to expose the injection point. Where the whole seal has to come away, a pull-ring seal or a tear-down design is used, and all-aluminium tear-off seals suit lines and products that do not want a plastic component. All of them are crimped the same way at this station.

Capping speed and what the seal contributes to it

On most lines the capper is set to keep up with the filler, and what stops it keeping up is rarely the crimping head: it is seals that do not feed, orient or seat at the rate the line runs. A bowl feeder sorts seals by how they sit and slide, so anything that changes shape from one seal to the next cuts how many reach the chute per minute.

Uniform height and profile. Seals that differ in height or profile inside a lot orient differently, so more are thrown back into the bowl.
Disc seating. On an aluminium-plastic seal, a loose or tilted disc changes how the seal runs in the feeder track and how the crimping head meets it.
Nesting. Seals that nest into each other feed in pairs, and a double seal on a vial is a reject and often a stop.
Bridges that survive feeding. The bridges between disc and skirt have to stay intact through the bowl, the chute and the head, or the disc arrives detached.
Shape damage. An out-of-round or dented seal jams the bowl or chute, and a jam stops the station, leaving filled, stoppered vials queuing under Grade A air supply with a validated hold time running.

How top design and finish affect line speed is covered in how seal design affects capping throughput. A buyer trialling a new seal usually runs samples through the line’s own feeder at production speed first, because that is where a mismatch shows.

Forms of supply and what they mean for an aseptic line

Only a Ready-to-Use seal can be passed straight into the aseptic core: it is gamma or ETO sterilized and double-bagged, so the outer bag is stripped at the airlock and the inner bag enters intact. Ready-to-Sterilize and Regular seals cannot, because they still need a validated sterilisation or washing cycle on site before they may cross that boundary. The choice of supply form is therefore a decision about line layout and on-site component preparation.

Ready-to-Use (RTU). Washed to remove particles, assembled in an ISO Class 8 cleanroom, double-lacquered, then gamma or ETO sterilized and double-bagged. This is the form for capping inside the aseptic core, and for sites that have no component sterilisation capacity of their own. Shelf life is 2 years before capping. RTU supply typically adds 1 to 2 weeks to a lead time for sterilisation and release, confirmed with the quotation.
Ready-to-Sterilize (RTS). Supplied clean and bagged, to be sterilised by the customer’s own validated cycle before entering the core. Suits sites that already run autoclave or tunnel capacity for stoppers and want the seals on the same route.
Regular. Non-sterile, for lines where capping is a clean process outside the aseptic core under a Grade A air supply, which is the common arrangement, and for terminally sterilised products. Shelf life is 3.5 years before capping, plus 5 years after capping.

Pack quantities per bag, in the specification table below, let a line plan how many bags cross the airlock per shift. Tyvek bagging is available where the site’s transfer procedure calls for it, and double bagging is standard for aseptic areas.

Dimensional consistency, throughput and rejects

At the capping station, dimensional consistency turns directly into throughput: a capping head is set once for a lot, so any drift in seal diameter, skirt height or metal gauge inside that lot shows up first as variation in the finished crimp and then as rejects. Beyond the feeding stops above, a loose tolerance costs a line in two ways:

Crimp variation. If skirt height varies, the amount of metal rolled under the flange varies with it, so the compression on the stopper varies. Some units come out under-crimped and loose, some over-crimped with a marked stopper or a chipped flange, and both are integrity rejects at the vision station rather than at the capper.
Head setting. A wide incoming tolerance forces the line to set the crimp head to a compromise that works across the spread instead of the nominal, which narrows the process window for everything else on the line.

That is why the useful specification for a filling line is not a single dimension but the spread around it. The dimensions in the table below are drawing-controlled, every seal passes 100% high-speed camera inspection before packing, and lots are sampled at AQL critical nil, major not more than 2.5% and minor not more than 4%.

Seal integrity: what the crimp has to deliver

A crimped seal does not itself form the sterile barrier; it holds the stopper compressed against the glass so the stopper can, and it has to keep doing that from the capping station to the last day of shelf life. Integrity is therefore a property of the stopper, the seal and the vial neck together, set at the moment of crimping.

The crimp delivers integrity through three things the line can control and the seal specification fixes:

Residual compression on the stopper. The force the crimped skirt keeps on the stopper flange after capping is what closes the leak path at the glass. Lines measure it as residual seal force and set the crimp head against it. Too little and the stopper can relax away from the glass; too much and the stopper or the flange is damaged.
Metal that stays where it was rolled. Aluminium thickness of 0.16 to 0.20 mm at 13 and 20 mm, and up to 0.25 mm at the larger sizes, is thick enough to hold the roll under the flange and thin enough to form cleanly without cracking.
A matched dimension chain. The vial neck finish, the seated stopper height and the seal’s skirt length have to close within the capping head’s window, as set out under closure integration below.

Integrity is then shown, not assumed, by the container closure integrity testing described under inspection and release. The broader treatment is in vial closure integrity. Tamper evidence is the other thing the finished crimp carries, visible to the person who opens the vial, and the designs that show it are on the tamper-evident vial seals page.

Seal specifications at the capping station

Controlled dimensions for the seals the capping station crimps, from the Autofits engineering drawings. The nominal size follows the vial neck finish under ISO 8362-1 and the stopper of the same nominal diameter.

Size	Inner Ø aluminium (D1)	Outer Ø disc (D2)	Total seal height	Aluminium thickness	Bridges	Max opening force	Standard packing per box
13 mm	13.36 mm (min)	14.99 mm (max)	7.62 to 8.38 mm	0.16 to 0.20 mm	6 taper	30 N	15,000 (5,000 × 3 bags)
20 mm	20.22 mm (min)	23.14 mm (max)	9.02 to 9.91 mm	0.16 to 0.20 mm	6 taper	35 N	6,000 per box
28 mm	27.60 to 28.20 mm	30.10 to 31.10 mm	11.06 to 12.06 mm	0.17 to 0.23 mm	8	35 N	3,000 (1,500 × 2 bags)
32 mm	32.10 to 32.90 mm	35.50 to 36.50 mm	14.30 to 15.50 mm	0.21 to 0.25 mm	12 taper	65 N	1,400 (700 × 2 bags)
34 mm	33.60 to 34.00 mm	35.50 to 36.50 mm	15.00 to 16.00 mm	0.20 to 0.25 mm	8 taper	On request	On request

Figures are for the FlipTop Optima flip-off range, made to ISO 8362-6 for aluminium-plastics combination caps. All-aluminium tear-off seals, made in 13, 20 and 32 mm, and the 20 mm all-aluminium tear-down seal relate to ISO 8362-3. Every size and design available at a given neck finish is listed on the seals by size index.

After capping: inspection, integrity and release

Once sealed, every unit is inspected, the package is shown to be integral, and the batch is documented and released. The steps run in this order:

External decontamination or washing. Sealed vials may be washed or wiped to remove residue before they leave the classified area.
100% visual inspection. Every filled unit is examined for visible particulates, fill volume, glass defects, and closure defects such as a missing, raised, loose or damaged seal. Manual, semi-automated and fully automated vision systems are all used; the expectations sit in USP <790> and the accompanying informational chapter on visual inspection. Sub-visible particulate limits are set separately, under USP <788>, and the seal’s own contribution to them comes from how it was washed, assembled and inspected before it reached the line.
Container closure integrity testing. Integrity is demonstrated by a leak test method chosen and validated within the framework of USP <1207>, applied at development, on stability, and per the control strategy in routine production.
Labelling and secondary packaging, with reconciliation of labels issued against units labelled.
Batch review and release, including the batch record, environmental monitoring results, the aseptic process simulation history for that line, and sterility and endotoxin testing as required.

Closure defects found at step 2 trace back to one of the stages above: a raised stopper that escaped the pre-capping check, a crimp head drifting across a lot, or a seal that arrived out of tolerance. Trending them by type is how a line tells a component problem from a machine problem.

How the closure system integrates with the line

Closure integration is a dimensional and behavioural problem: the vial, stopper and seal have to fit each other, and the seal has to feed and crimp identically thousands of times an hour. Three things carry most of the risk.

The dimension chain. Vial neck finish, seated stopper height and seal skirt length stack up. The ISO 8362 series exists to keep that stack compatible: ISO 8362-1 for tubing vials, Part 2 for closures, Part 3 for plain aluminium caps, and Parts 6 and 7 for aluminium-plastics combination caps. If one component is sourced against a different drawing, the crimp window moves.
Cleanliness of the incoming component. Loose particles or coating debris on a seal end up on the outside of a sterile vial and, in the worst case, inside the crimp interface.

Because of that stack-up, the vial, stopper and seal are qualified together for a product rather than individually, and a change to any one of them is assessed against the other two. Sourcing the stopper and the seal to the same nominal size and against the same neck drawing is the simplest way to keep that assessment short.

What to send when specifying a seal for a fill-finish line

A seal can be matched to a line from six pieces of information, and a sample run through the line’s own feeder is the step that confirms it. Send these through the contact page:

The vial neck finish and nominal size (13, 20, 28, 32 or 34 mm), and the vial drawing if it is not a standard ISO 8362-1 finish.
The stopper reference already qualified with the product, so the seal drawing is matched to its flange.
The seal family and top design: flip-off (bridge, button or flower), pull-ring, tear-down or tear-off.
Where capping happens relative to the aseptic core, which sets the delivery form: Regular, Ready-to-Sterilize or Ready-to-Use.
Colour and finish, if a colour code is used to separate products or strengths on the line.
Expected volume per size and colour.

Standard samples are typically 200 to 500 pieces per size, dispatched typically within 5 working days, which is enough to run a feeder and crimp trial. The sample request page sets out what can be sampled and in which forms.

How this works in practice at Autofits

Autofits sits on the component stream of the chain described above, supplying the seals that the capping station crimps at the end of it: FlipTop aluminium-plastic seals in the Optima, Pull Ring and Tear Down designs, all-aluminium tear-off and tear-down seals, and aluminium pilfer-proof (ROPP) caps for bottled products. Because the seal arrives at the last controlled step before a vial is closed, it is produced to tight dimensional tolerances from AA8011 aluminium with an epoxy lacquer to 21 CFR 175.300 and a polypropylene disc to 21 CFR 177.1520, moulded in house on Japanese Toyo injection machines, washed on a fully automated line, and screened by 100% high-speed camera inspection, so it feeds and crimps predictably on a customer’s line. Ready-to-Use seals are washed, assembled in an ISO Class 8 cleanroom, double-lacquered, gamma or ETO sterilized and double-bagged for transfer into an aseptic area. Production runs in a 75,000 sq ft Nashik facility under an ISO 15378:2017 quality system alongside ISO 9001:2015 and ISO 14001:2015 certification and Drug Master File 18100, with output of more than 2.4 billion seals a year.

Frequently asked questions

What is the vial fill-finish process?

Vial fill-finish is the final manufacturing stage for an injectable drug, covering everything from a formulated bulk solution to sealed, inspected vials ready for release. It combines a product stream (compounding, bioburden control, sterile filtration) with a component stream (vial washing and depyrogenation, stopper preparation, seal supply), then fills, stoppers, freeze-dries where required, caps, inspects, integrity-tests, labels and releases.

What are the stages of a fill-finish line in order?

Component preparation and sterile filtration run in parallel, then the line runs: filling, stoppering, lyophilisation if the product is freeze-dried, capping, external decontamination, 100% visual inspection, container closure integrity testing, labelling and secondary packaging, and batch review and release.

Where does the seal enter a fill-finish line?

The seal enters at the capping station, immediately after stoppering, and after lyophilisation where the product is freeze-dried. Seals are fed from a hopper or bowl feeder, oriented, singulated and placed on each stoppered vial, then crimped under the neck flange. It is the step that completes the container closure system; everything after it, inspection, integrity testing and labelling, verifies and finishes a package that is already closed.

Does capping have to happen inside the aseptic core?

No. EU GMP Annex 1 allows capping of aseptically filled product as an aseptic process using sterilised caps or as a clean process outside the aseptic processing area, and outside is common because crimping equipment can generate large quantities of particles. The location decides which delivery form of seal the line can use.

What does a Grade A air supply at capping mean?

EU GMP Annex 1 defines a Grade A air supply as air passed through a filter qualified to produce Grade A total particle quality, without the continuous total particle monitoring or Grade A viable limits required of a Grade A zone. It is used to protect fully stoppered vials from the point they leave the aseptic processing area until the cap is crimped, with a background environment of at least Grade D.

Which form of seal supply can go into an aseptic core?

Only Ready-to-Use seals go straight in: they are gamma or ETO sterilized and supplied double-bagged, so the outer bag is removed at the airlock and the inner bag enters intact. Ready-to-Sterilize seals are clean and bagged but need the customer’s own validated cycle first, and Regular seals are non-sterile and suit capping performed as a clean process outside the core under a Grade A air supply.

How does seal consistency affect capping throughput?

A capping head is set once for a lot, so variation within that lot becomes variation in the finished crimp. An out-of-round or dented seal can jam the feeder and stop the station, which backs up filled vials behind it, and drift in skirt height changes how much metal rolls under the flange, producing under-crimped or over-crimped units that are rejected at the vision station. A tight, verified spread around the nominal dimension keeps the crimp window wide.

Why are vials depyrogenated before filling?

Because sterilisation kills organisms but does not destroy the bacterial endotoxin they leave behind, and endotoxin in an injectable causes a pyrogenic reaction. Glass vials are therefore passed through a dry heat tunnel after washing, on a cycle validated to reduce a bacterial endotoxin challenge by at least 3 log, commonly at 250 °C or above. USP <1228.1> covers dry heat depyrogenation.

What does EU GMP Annex 1 require at the capping step?

Where capping is a clean process with Grade A air supply protection, Annex 1 asks for vials with missing or displaced stoppers to be rejected before capping, using qualified automated stopper-height detection. Crimping equipment that generates large quantities of particles should be separated, for example in a physically separate station with adequate air extraction, and where people intervene at the capper, measures should prevent direct contact with the vials. Every filled container is then inspected individually.

What has to match between the vial, stopper and seal?

The vial neck finish, the seated height of the stopper, and the seal’s diameter and skirt length form a dimension chain that has to close within the capping head’s window. The ISO 8362 series dimensions these components to be compatible with each other. Because the tolerances stack, the three are qualified together for a product and a change to one is assessed against the other two.

Sources

European Commission: EudraLex Volume 4, EU GMP Annex 1, Manufacture of Sterile Medicinal Products (2022), sections 8.26 to 8.30 and glossary (https://health.ec.europa.eu/medicinal-products/eudralex/eudralex-volume-4_en)
FDA: Guidance for Industry, Sterile Drug Products Produced by Aseptic Processing, Current Good Manufacturing Practice, September 2004 (https://www.fda.gov/regulatory-information/search-fda-guidance-documents/sterile-drug-products-produced-aseptic-processing-current-good-manufacturing-practice)
USP-NF: General Chapter <1228.1>, Dry Heat Depyrogenation (https://www.usp.org/)
USP-NF: General Chapter <790>, Visible Particulates in Injections (https://www.usp.org/)
USP-NF: General Chapter <1207>, Package Integrity Evaluation, Sterile Products (https://www.usp.org/)
USP-NF: General Chapter <381>, Elastomeric Components in Injectable Pharmaceutical Product Packaging/Delivery Systems (https://www.usp.org/)
EDQM: European Pharmacopoeia 3.2.9, Rubber closures for containers for aqueous parenteral preparations, for powders and for freeze-dried powders (https://www.edqm.eu/en/european-pharmacopoeia)
ISO: ISO 8362-1:2018, Injection containers and accessories, Part 1: Injection vials made of glass tubing (https://www.iso.org/standard/74398.html)
ISO: ISO 8362-6:2010, Injection containers and accessories, Part 6: Caps made of aluminium-plastics combinations for injection vials (https://www.iso.org/standard/52806.html)
Autofits FlipTop Seals dossier and engineering drawings; Autofits brochure (https://autofits.com/wp-content/uploads/2024/07/Autofits-Brochure.pdf)

*Last updated: 2026-09-15. This article is general technical information, not regulatory or compliance advice; confirm current standard editions and requirements with the issuing bodies.*